World Sickle Cell Day is observed on 19 June every year to promote public awareness regarding sickle cell disease and its treatment methods. Sickle cell disease (SCD) is an inherited genetic abnormality of haemoglobin. This causes stuck in small blood vessels, which can decrease blood flow and oxygen to parts of the body. Normally, red blood cells are round that can move easily through the blood vessels. In sickle cell anemia, the red blood cells become rigid and sticky. Red blood cells can live up to 120 days before the body needs to replace them, while sickle cells last only 10 to 20 days causing anaemia because of red blood cells disorder.
DelveInsight Blog
Related Article
Lyfgenia or Casgevy: Who Will Lead the Sickle Cell Disease Treatment Space?
History has been created as the world captures the significance of the FDA’s approval of Casgevy (exa-cel), a collaboration between Vertex Pharmaceuticals and CRISPR Therapeutics, for the treatment of sickle cell disease (SCD). This groundbreaking therapy represents a long-awaited potential cure for the debilitatin...
Find MoreMerck and Moderna Initiate Study to Evaluate V940; FDA Approves Vertex and CRISPR Therapeutics’ CASGEVY for SCD; Novartis Updated on its Investigational Iptacopan Phase III Study; FDA Grants Priority Review for New Drug Application for Elafibranor; FDA Approves bluebird bio’s LYFGENIA for Patients SCD; FDA Fast Track Designation for DMD Gene Therapy
Merck and Moderna Initiate INTerpath-002, a Phase III Study Evaluating V940 in Combination with KEYTRUDA for Adjuvant Treatment of Patients with Certain Types of Resected NSCLC Merck (also known as MSD outside the United States and Canada) and Moderna, Inc. have commenced the INTerpath-002 trial—a crucial Phase ...
Find MoreCell and Gene Therapies in Rare Disorders: From Rarity to Recovery
The cell and gene therapy market has seen a revolutionary transition in recent years, with advancements in scientific research and novel methods of treatment driving a rise in development activities. This has resulted in an increase in the number of cell and gene therapy choices available to patients suffering from...
Find MoreEditor's Pick
Newsletter/Whitepaper
Recent Article
ASCO Conference 2023
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.